Health

Sputnik Light can become a major booster for those vaccinated with inactivated Chinese COVID vaccines globally after China has officially recommended mix & match approach with adenoviral vector-based vaccines as boosters

There are 2 billion people who have received inactivated Chinese vaccines in the country and globally. As China has just authorized mix & match boosting with domestic vaccines, the Russian one-shot Sputnik Light vaccine can become a universal booster for those vaccinated with Chinese vaccines in other countries around the world to strengthen and lengthen […]

thaipr.net

21 ก.พ. 65

NIBIOHN, Shionogi Discover Host Immune-dependent Novel Anti-coronavirus Antibody

Potential Candidate as Broad-spectrum Therapeutic Agent for Coronavirus Diseases Caused by Different Coronaviruses, including Variants – The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN; Ibaraki-shi, Osaka; Director-general: Yoshihiro Yoneda), in partnership with Shionogi & Co., Ltd. (Chuo-ku, Osaka; President and CEO: Isao Teshirogi), has successfully identified a novel antiviral antibody for severe…

thaipr.net

17 ก.พ. 65

HPG: New Breakthrough in Virus Inactivation with Green Tea Catechin (EGCg)

HPG Co., Ltd. (Chuo-ku, Tokyo) has successfully developed a water-soluble formulation technology of highly concentrated catechin EGCg (Epigallocatechin gallate) with excellent storage stability and initiated procedures for a patent application for the technology to stabilize the product at a high concentration in aqueous solution. Green tea catechin EGCg has inactivating effects against viruses. However, it […]

thaipr.net

15 ก.พ. 65

Clinical trials in Russia and Azerbaijan demonstrated safety of AstraZeneca and Sputnik Light vaccines combination

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), R-Pharm group and AstraZeneca announce interim results of phase II clinical trials to evaluate the safety and immunogenicity of the combined use of AstraZeneca’s vaccine and the first component of the Sputnik V coronavirus vaccine (Sputnik Lite). According to the interim results of the trials, […]

thaipr.net

14 ก.พ. 65

Zimmer Biomet Opens ZBEdge Customer Experience Centre in Singapore to Drive Robotics and Medical Technology Transformation

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today celebrated the opening of the ZBEdge Customer Experience Centre (CEC), a unique facility located at the company’s Asia Pacific regional headquarters in Singapore. The ZBEdge Customer Experience Centre is a state-of-the-art facility that showcases Zimmer Biomet’s latest technologies – ROSA® robotics, mymobility® digital […]

thaipr.net

11 ก.พ. 65

Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial

– PREVENT-19 pediatric expansion in adolescents aged 12 through 17 achieved primary effectiveness endpoint demonstrating comparability to adult population – Trial demonstrated 82% clinical efficacy against Delta variant – Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied – Vaccine was well-tolerated with no safety signals identified – Novavax plans to…

thaipr.net

11 ก.พ. 65

X-Chem and Excelra’s GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets

A new collaboration between data science and analytics leader, Excelra, and artificial intelligence pioneer X-Chem will accelerate preclinical drug discovery and aid scientists to find new drug candidates for currently hard-to-drug targets. Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates. This synergistic new partnership between Excelra’s GOSTAR and X-Chem’s RosalindAI…

thaipr.net

11 ก.พ. 65

Well Begun AND Half Done! – SIRONA Randomized Trial Achieves fifty percent enrollment

Concept Medical Inc., focused on vascular intervention drug delivery devices, releases the second status update of SIRONA RCT (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery), as the trial completes half the targeted enrolment. SIRONA is the world’s first and the largest head-to-head RCT investigating the use of Sirolimus DCB (Magic Touch PTA – Concept […]

thaipr.net

11 ก.พ. 65
1 … 79 80 81 82 83 … 128

Copyright © 2025 Dataxet Limited (บริษัท ดาต้าเซ็ต จำกัด). All Rights Reserved.